On January 20, 2023, the U.S. Centers for Disease Control & Prevention (CDC) warned about a potential link between EzriCare and other artificial eye drops and antibiotic-resistant infections. According to a recently released however, a woman came to the emergency room at the Cleveland Medical…
The U.S. Food and Drug Administration (FDA) recently announced the recall of two more brands of eye drops due to potential contamination with antibiotic-resistant bacteria. This latest recall comes only a few weeks after Global Pharma announced the recall of EzriCare and Delsam Pharma eye…
Horizon Pharmaceuticals—makers of thyroid eye disease medication Tepezza—recently filed a motion to dismiss a recent lawsuit filed by a plaintiff who claims the medication caused her to suffer from permanent hearing loss. The plaintiff stated in her complaint that she received Tepezza infusions to treat…
The U.S. Centers for Disease Control and Prevention (CDC) recently warned that it is investigating a potential outbreak of bacterial infections that may be related to the use of EzriCare Artificial Tears. While this investigation is ongoing, the CDC has recommended that consumers immediately stop…
Amid a rising number of lawsuits filed against the makers of Tepezza for hearing loss, a new study reports that the thyroid eye disease (TED) drug may also increase the risk of hyperglycemia, or low blood sugar. Tepezza is the only FDA-approved treatment for TED.…
Makers of infant formula have faced increasing scrutiny over the past several months as more parents become aware of issues affecting their babies’ health. Many have filed lawsuits against Abbott Laboratories, the makers of Similac, and Mead Johnson, the makers of Enfamil, after the parents’…
Amid rising awareness of the potential for baby formula to increase the risk of a dangerous intestinal disease in premature infants, the U.S. Food and Drug Administration (FDA) recently received a new petition asking for a ban on toxic baby formula additives. The Center for…
On September 16, 2021, Pfizer expanded the nationwide Chantix (varenicline) recall to include all lots of the medication due to potentially unsafe levels of the carcinogen N-nitroso-varenicline. Now, the company faces increasing litigation from consumers who have used its Chantix products. One of those is…
The U.S. Food and Drug Administration (FDA) recently announced that Pfizer is expanding its voluntary Chantix (varenicline) recall to include all lots of 0.5 mg and 1 mg tablets. The company is pulling these products from the shelves because of unacceptable levels of N-nitroso-varenicline, an…
The U.S. Food and Drug Administration (FDA) recently required the manufacturers of arthritis medications Xeljanz (tofacitinib) and Xeljanz XR (extended-release) to add new warnings to their medications. These warnings will alert doctors and patients to an increased risk of serious heart-related events such as heart…
